CLINICIAN AWARENESS, ATTITUDES, AND INTEREST IN BLOOD TESTS FOR ALZHEIMER’S DISEASE

Karen Tracy, Julie Wood, Ben Tiede, Emily Scholler · 2024

Read CLINICIAN AWARENESS, ATTITUDES, AND INTEREST IN BLOOD TESTS FOR ALZHEIMER’S DISEASE by Karen Tracy, Julie Wood, Ben Tiede, Emily Scholler (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11691828.txt.

Description

Karen Tracy and co-authors survey clinicians on blood tests for Alzheimer's disease, in work from twenty twenty-four. Blood based markers of amyloid and tau could make diagnosis faster and cheaper than brain scans or spinal fluid tests. A global initiative is preparing clinics for wide use of such tests.

Family doctor and aging society members answered surveys in spring twenty twenty-four. They shared current awareness of the tests, views on their value, and how they might use them in practice. They also named what they need to trust the tests: more knowledge and clearer guidance. Early detection matters since timely diagnosis still lags in clinics. The results guide training for the roll out.

Catalog record

CREATORKaren Tracy, Julie Wood, Ben Tiede, Emily Scholler
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE1 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11691828

Browse the full library · About the Tower of Babel